Abstract
Donor optimization is vital to increase donor hearts utilized for transplantation. We report a case of a 34‐year‐old female with end‐stage cardiomyopathy that was admitted to the intensive care unit on inotropic support with progressive decline (INTERMACS‐2). She was offered a donor heart from a 14‐year male that was found to have Klebsiella pneumoniae bacteremia and candidemia co‐infection. The donor was transferred to our hospital and optimized hemodynamically and biochemically. Targeted antimicrobial and antifungal therapy based on the susceptibility testing was established in the donor till blood cultures were negative. The recipient received similar prophylactic therapy for 2‐week course starting 24‐h before transplantation. The patient was transplanted with no clinical consequences. She was discharged home in 4 weeks post‐transplantation. Her 3‐month follow‐up was completely uneventful.